Please login to the form below

Not currently logged in
Email:
Password:

Gliadel

This page shows the latest Gliadel news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Even agents approved within the last decade - a wafer formulation of carmustine (Gliadel) for implantation into the post-surgical tumour cavity and temozolomide (Temodal), an oral imidazotetrazine derivative of the alkylating

Latest news

  • Early 2013 sees drug filings, launches and approvals in Japan Early 2013 sees drug filings, launches and approvals in Japan

    Eisai and Nobelpharma have launched brain cancer drug Gliadel (carmustine), which becomes the only sustained-release formulation approved for intracranial implantation in Japan. ... Nobelpharma acquired manufacturing and marketing rights to Gliadel from

  • Back on track

    Gliadel wafers are implanted in the tumour cavity created in the brain after surgical removal and release carmustine slowly, directly to the tumour site. ... Gliadel has been shown to prolong the survival of patients significantly compared with those

  • New accounts: October

    Dermatology. Life. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Napp Pharmaceuticals. New product.

  • New accounts: November

    Pulsar Healthcare Communications. Link Pharmaceuticals. Gliadel implant. Oncology. Addjuice. Mayne Pharma.

  • New accounts: August

    Janssen-Cilag. Lyrinel XL. Urinary incontinence. PBC Communications. Link Pharmaceuticals. Gliadel implant.

More from news
Approximately 1 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...